Cargando…

Radionuclide Methods in the Diagnosis of Sacroiliitis in Patients with Spondyloarthritis: An Update

Sacroiliitis, inflammation of the sacroiliac joint (SIJ), is the hallmark of ankylosing spondylitis and spondyloarthritis (SpA) in general. The arsenal of recommended diagnostic modalities for imaging of the SIJ is scanty and, in practice, includes only conventional X-rays and magnetic resonance ima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilber, Karina, Gorenberg, Miguel, Rimar, Doron, Boulman, Nina, Kaly, Lisa, Rozenbaum, Michael, Rosner, Itzhak, Slobodin, Gleb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rambam Health Care Campus 2016
Materias:	Special Issue on Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101011/ https://www.ncbi.nlm.nih.gov/pubmed/27824544 http://dx.doi.org/10.5041/RMMJ.10264

Ejemplares similares

Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment
por: Awisat, Abid, et al.
Publicado: (2023)

Tocilizumab Efficacy in a Patient with Positive Anti-CCP Chronic Lyme Arthritis
por: Hirsch, Julianna, et al.
Publicado: (2016)

Ulcerative Colitis and Familial Mediterranean Fever: Can Anakinra Treat Both?
por: Kaly, Lisa, et al.
Publicado: (2019)

Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy
por: Hirsch, Julianna, et al.
Publicado: (2016)

P01-009 – 2 years of colchicine IV in intractable FMF
por: Kaly, L, et al.
Publicado: (2013)

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever
por: Rimar, D, et al.
Publicado: (2015)

Sacroiliitis – early diagnosis is key
por: Slobodin, Gleb, et al.
Publicado: (2018)

P01-010 – Anti-TNF agents in intractable FMF: four cases
por: Kaly, L, et al.
Publicado: (2013)

Chikungunya Virus Infection: An Update on Joint Manifestations and Management
por: Krutikov, Maria, et al.
Publicado: (2016)

Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update
por: Nesher, Gideon, et al.
Publicado: (2016)

Variant CAPS in an adult- the use of genetics
por: Rozenbam, M, et al.
Publicado: (2015)

Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns
por: Londono, John, et al.
Publicado: (2015)

(Un)Spoken realities of living with axial spondyloarthritis: a qualitative study focused on couple experiences
por: Raybone, Kerry, et al.
Publicado: (2019)

Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases
por: Mougui, Ahmed, et al.
Publicado: (2023)

Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining
por: Pearson, Nathan Ashley, et al.
Publicado: (2022)

Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study
por: Andreasen, Rikke Asmussen, et al.
Publicado: (2017)

The Prevalence of Sacroiliitis and Spondyloarthritis in Patients with Sarcoidosis
por: Kobak, Senol, et al.
Publicado: (2014)

Association of anxiety, depression and resilience with overall health and functioning in axial spondyloarthritis (axSpA): a cross-sectional study
por: Chung, Deborah Xin Yi, et al.
Publicado: (2023)

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
por: Benavent, Diego, et al.
Publicado: (2022)

Effectiveness and cost-effectiveness of combined asynchronous telemonitoring and patient-initiated care for spondyloarthritis: protocol for a pragmatic multicentre randomised controlled trial (TeleSpA Study)
por: Hermans, Kasper, et al.
Publicado: (2023)

GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
por: Couderc, Marion, et al.
Publicado: (2020)

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
por: Uhrenholt, Line, et al.
Publicado: (2019)

Citrullination in Rheumatoid Arthritis—A Process Promoted by Neutrophil Lysis?
por: Gazitt, Tal, et al.
Publicado: (2016)

ACPAs Are Much More Than Diagnostic Autoantibodies
por: Watad, Abdulla, et al.
Publicado: (2016)

The Role of γδ T Cells in Fibrotic Diseases
por: Bank, Ilan
Publicado: (2016)

Targeted Therapy in Systemic Sclerosis
por: Baron, Murray
Publicado: (2016)

Systemic Sclerosis and the Gastrointestinal Tract—Clinical Approach
por: Braun-Moscovici, Yolanda, et al.
Publicado: (2016)

Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention
por: Bubbear, Judith Sarah
Publicado: (2016)

Ehlers–Danlos Syndrome—Hypermobility Type: A Much Neglected Multisystemic Disorder
por: Gazit, Yael, et al.
Publicado: (2016)

Cocaine-Induced Vasculitis
por: Berman, Mark, et al.
Publicado: (2016)

The Emerging Role of Mitochondrial Dysfunction in the Pathogenesis of Idiopathic Inflammatory Myopathies
por: Gonzalez-Chapa, Jorge Armando, et al.
Publicado: (2023)

Biological Therapies in Inflammatory Myopathies
por: Natour, Abd El Haleem, et al.
Publicado: (2023)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
por: Furer, Victoria, et al.
Publicado: (2023)

Idiopathic Eosinophilic Vasculitis: Case Presentation and Literature Review
por: Broyde, Adi, et al.
Publicado: (2023)

Implementation of Calcium and Vitamin D Supplementation in Glucocorticosteroid-Induced Osteoporosis Prevention Guidelines—Insights from Rheumatologists
por: Gazitt, Tal, et al.
Publicado: (2023)

Immunohistological analysis of active sacroiliitis in patients with axial spondyloarthritis
por: Peng, Jianhua, et al.
Publicado: (2017)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
por: Poddubnyy, Denis, et al.
Publicado: (2020)

Updated Treatment for Calcium Pyrophosphate Deposition Disease: An Insight
por: Iqbal, Shumaila M, et al.
Publicado: (2019)

The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2022)

The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging
por: Wang, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d3jqgvlg14ro2o1m4umu3u30ek